FHI 360 is conducting a two-year clinical intervention trial that aims to promote adherence to a highly effective antiretroviral therapy among HIV-positive Chinese patients at an HIV clinic in Guangxi Province. Using an electronic pill container called “Wisepill,” the project assesses real-time feedback, which generates preliminary data on the effectiveness of adherence.
To support this study, FHI 360 provides technical direction to our local partner at the clinic, strengthens capacity of staff and oversees study administration and logistics. In addition to adherence and clinical data, quantitative and qualitative data will be collected using survey instruments, focus groups and in-depth interviews. An analysis of this data will contribute to the scientific evidence base on effective approaches to promoting antiretroviral therapy adherence among injecting drug users and other patients.
FHI 360 is conducting this trial in partnership with the Center for Global Health and Development at the Boston University School of Public Health.